Investment type
Equity - Shares of Stock
Class
Common Shares
Latest Disclosed Ownership
509K shares
Security Ownership
19.9%

Hanmi Pharmaceutical Co., Ltd. ownership in Aptose Biosciences Inc. Common Shares

2025-03-20 - Hanmi Pharmaceutical Co., Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 509K shares of Aptose Biosciences Inc. Common Shares. This represents 19.9% percent ownership of the company.